Running News and Research

RSS

Ventus' PROVENT Sleep Apnea Therapy is runner-up at the The Wall Street Journal Technology Innovation Awards

Ventus Medical, a privately-held medical device company focused on improving the lives of patients with sleep-disordered breathing, today announced that the company's PROVENT(R) Sleep Apnea Therapy received the Runners-Up Award in The Wall Street Journal 2009 Technology Innovation Awards, Medical Devices category. The results were published in the September 14, 2009 edition of The Wall Street Journal.

22 Sep 2009

Paralyzed rats can walk and run: UCLA scientists

UCLA researchers have discovered that a combination of drugs, electrical stimulation and regular exercise can enable paralyzed rats to walk and even run again while supporting their full weight on a treadmill.

21 Sep 2009

Bruker declares secondary offering of common stock shares

Bruker Corporation today announced an underwritten public secondary offering of 12,000,000 shares of its common stock by two members of the Laukien family not involved in the Company’s business.

18 Sep 2009

Biopharmaceutical company announces initial public offering

Omeros Corporation today announced the launch of its initial public offering of 6.82 million shares of its common stock. Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system.

18 Sep 2009

Rigel to offer 13,000,000 shares of its common stock at a price to the public of $7.25 per share

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the pricing of an underwritten public offering of 13,000,000 shares of its common stock at a price to the public of $7.25 per share.

18 Sep 2009

SXC Health Solutions to raise $176.6 million from sale of common shares

SXC Health Solutions Corp. ("SXC" or the "Company") (NASDAQ: SXCI, TSX: SXC) announced today the pricing of its previously announced public offering of common shares. Under the offering, SXC will sell 4,500,000 common shares at a price to the public of $41.50 per share.

18 Sep 2009

Researchers study the role of stem cells in development of liver cancer

Penn State College of Medicine researchers, in collaboration with colleagues at the University of Southern California, have taken an important step in understanding the role of stem cells in development of liver cancer.

18 Sep 2009

With Baucus Bill no longer a mystery, party leaders contemplate strategy

Now that the long-awaited Baucus health overhaul is out, Democratic leaders are pondering how they will collect the votes and support necessary to move a bill through Congress.

18 Sep 2009

Government-run health care and increased taxes top list of concerns

On the heels of the new $856 billion health care bill proposed yesterday by Senate Finance Committee Chairman Max Baucus, doubt over health care reform passing this year still looms across the American public.

18 Sep 2009

New tool developed to provide precise and cost-effective data collection for drug discovery efforts

Cancer and cell biology experts at the University of Cincinnati (UC) have developed a new mass spectrometry-based tool they say provides more precise, cost-effective data collection for drug discovery efforts.

18 Sep 2009

Rising trend in youth sports-related injuries

Thirty million children and teens are busy gearing up for the fall athletic season. What they're not gearing up for is a sprained, strained or fractured ankle. However, US Consumer Product Safety Commission statistics reveal 3.5 million children and teens get hurt annually playing organized and/or school sports.

18 Sep 2009

Findings may lead to drugs that destroy TB in dormant stage of lifecycle

Attempts to eradicate tuberculosis (TB) are stymied by the fact that the disease-causing bacteria have a sophisticated mechanism for surviving dormant in infected cells. Now, a team of scientists led by researchers from Weill Cornell Medical College has identified compounds that inhibit that mechanism -- without damaging human cells.

17 Sep 2009

Phase Forward advances its clinical trial and drug safety data management capabilities

For many large pharmaceutical and medical device firms, the task of capturing and managing volumes of clinical trial and drug safety data is often outsourced to experts like Phase Forward.

16 Sep 2009

Free caregivers provided to veterans and their spouses by TheraCare

Now, free long term care services, both home and community based, are being offered to qualified veterans and their spouses by TheraCare Home Health and Staffing, LLC.

16 Sep 2009

MDVIP's medical director suggests preventive measures for flu

Dr. Bernard Kaminetsky, the medical director of MDVIP, a national network of affiliated primary care doctors focused on preventive care, recommends, “Talk to your primary care physician now about the flu, both seasonal and H1N1 flu. Your primary care doctor is the one who can best prepare you for the upcoming season with vaccinations as well as information specific to you.”

16 Sep 2009

Stem cells - the answer to autoimmune diseases and cancer in the future

Stem cells are multipotent cells of the immune system. Scientists hope to use them for curing autoimmune diseases, cancer and innate genetic defects in the future.

16 Sep 2009

Neuroskin Psoriasis Relief DRTV test results announced by avVaa World Health Care

avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the results of its first DRTV test week.

15 Sep 2009

Talecris launches initial public offering of shares

Talecris Biotherapeutics Holdings Corp. (“Talecris”) today announced the launch of its initial public offering of 44,736,842 shares of its common stock, par value $0.01 per share.

15 Sep 2009

PHLI announces marketing campaign for FORZE GPS bars and drinks

PacificHealth Laboratories, Inc. (OTCBB: PHLI), a leading sports nutrition company, is pleased to announce three marketing initiatives for FORZE GPS™ bars and drinks, the first scientifically proven appetite control tools created specifically for athletes.

15 Sep 2009

Children's Hospital and eClinicalWorks collaborate to implement PCHR

Children's Hospital Boston and eClinicalWorks(R) today announced a collaboration that will enable patients who are seen at Children's ambulatory programs and in primary care practices in the Pediatric Physicians' Organization at Children's (PPOC) to aggregate health data from both sites of care into a single personally controlled health record (PCHR).

15 Sep 2009